Trials / Completed
CompletedNCT05919628
Psychological Ressources, Anxiodepressive Symptoms, Well-being and Therapeutical Observance in Parkinson's Disease
Psychological Ressources as a Protective Factor for Anxiety-depression, Well-being and Therapeutical Observance in Parkinson's Disease.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Anxiodepressive symptoms are frequently observed in Parkinson's disease patients. These non motor psychiatric charateristics of the disease negatively impairs quality of life, and may impair well-being or therapeutical observance. The objective of this study is to determine if psychological ressources are associated to anxiodepressive symptoms, to parkinson well-being and therapeutical observance. It will be interesting to determine if the presence of some - or multiple- psychological ressources could prevent patients from anxiety, depression, impaired well-being and impaired observance. This study will analyse retrospectively psychological scalescompleted by 30 parkinson's disease patients through previous psychological interviews. The scales investigate anxiety, depression, well-being, psychological ressources, and therapeutical observance. The results will highlight the importance of working on psychological ressources with Parkinson's disease patients through psychotherapy, in order to improve their well-being, positive emotions and maybe contribute to better therapeutical observance.
Detailed description
The scales used are : * The SPANE * The PAS * The LOT-R * The SCS * The brief BDI * The SSAM * The HAD * The MAAS * An observance scale
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | ResPsyPark group | Evaluation of the parkinson's disease patient's score over different psychological questionnaires and a therapeutical observance questionnaire |
Timeline
- Start date
- 2023-06-15
- Primary completion
- 2023-06-15
- Completion
- 2023-06-30
- First posted
- 2023-06-26
- Last updated
- 2023-09-06
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05919628. Inclusion in this directory is not an endorsement.